Medicare open enrollment begins: What to expect for 2027
Medicare’s 2027 open enrollment period includes newly negotiated prices for 15 prescription drugs. The article also reports a proposed one-time $90 Part B premium rebate for some eligible beneficiaries.
Source: Kfvs12 ·
Grace's Take
If you take a widely used medication like Ozempic or Wegovy, your out-of-pocket costs could drop meaningfully once these newly negotiated prices land in 2027. For someone in their mid-50s expecting to hit Medicare at 65, this matters: prescription drug costs often consume a meaningful portion of retirement income. Knowing which medications will have lower negotiated prices gives you a clearer picture of healthcare spending in early retirement. Worth checking during open enrollment whether any medications you currently take or anticipate needing appear on the 2027 negotiated drug list—it could shift how you budget healthcare costs once you retire.
- •Negotiated Medicare prices for 15 drugs are scheduled to take effect in 2027.
- •The listed drugs include Ozempic, Wegovy and other widely used medications.
- •Some eligible beneficiaries may receive a one-time $90 Part B rebate.
People approaching or living in retirement should review their drug coverage during open enrollment because negotiated prices and eligibility for premium assistance could affect annual healthcare costs.